Related Experiment Videos
Expression of C-myc p62 oncoprotein in multiple myeloma: an immunohistochemical study of 180 cases
A Skopelitou1, M Hadjiyannakis, A Tsenga
1Pathology Department, University of Athens Medical School, Greece.
Abstract:
The immunohistochemical expression of C-myc p62 oncoprotein was investigated using the immunoperoxidase method and the monoclonal antibody (Mab) MYC 1-9E10 in bone marrow paraffin sections. 180 cases of multiple myeloma (MM) were studied. C-myc expression was found to correlate well with the grade of malignancy, type of myeloma and tumor cell burden (p < 0.001). A relationship was also observed between C-myc p62 and IgA-secreting myelomas. It was found that intermediate grade myelomas are heterogeneous as far as C-myc expression is concerned. Our findings strongly suggest that C-myc might be involved in myelomutagenesis. The evaluation of its expression in MM may be helpful in determining the grade of malignancy and possibly the biological behaviour of this tumor.
Insights
C-myc p62 oncoprotein expression in multiple myeloma (MM) correlates with malignancy grade and tumor burden. This suggests C-myc
Area of Science:
- Oncology
- Hematology
- Molecular Biology
Background:
- Multiple myeloma (MM) is a malignancy of plasma cells.
- Understanding the molecular drivers of MM progression is crucial for improved diagnostics and therapeutics.
Purpose of the Study:
- To investigate the immunohistochemical expression of C-myc p62 oncoprotein in multiple myeloma.
- To correlate C-myc p62 expression with clinical parameters of MM.
Main Methods:
- Immunohistochemistry using the immunoperoxidase method and monoclonal antibody MYC 1-9E10.
- Analysis of 180 bone marrow paraffin sections from multiple myeloma patients.
Main Results:
- C-myc p62 expression significantly correlated with malignancy grade, myeloma type, and tumor cell burden (p < 0.001).
- A specific association was noted between C-myc p62 and IgA-secreting myelomas.
- Intermediate grade myelomas exhibited heterogeneous C-myc p62 expression patterns.
Conclusions:
- C-myc p62 expression is a potential biomarker for assessing multiple myeloma malignancy grade and biological behavior.
- Findings suggest a role for C-myc in myelomagenesis, the process by which normal cells transform into myeloma cells.